Genmab/AbbVie’s Epkinly Likely To See Label Expansion After Phase III Win

Drug’s Sales Soar In Genmab Q2 Earnings

 
• By Alaric DeArment
  
Bispecific AB
• Source: Shutterstock

More from Clinical Trials

More from R&D